Weiya Xia
- Oncology top 0.1%
- Cancer-related Molecular Pathways 19
- Cancer Cells and Metastasis 10
- HER2/EGFR in Cancer Research 10
- Cancer Research top 0.2%
- Molecular Biology top 0.2%
- RNA Interference and Gene Delivery 12
- Epigenetics and DNA Methylation 10
- Cell death mechanisms and regulation 9
- Immunology top 1%
- Aging top 1%
-
- Virus-based gene therapy research 14
-
- Monoclonal and Polyclonal Antibodies Research 10
- Co-authors
- Mien‐Chie HungBinhua P. ZhouBill SpohnYongkun WeiYong LiaoGabriel N. HortobágyiShiaw‐Yih LinJiong Deng
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Weiya Xia
114 papers receiving 17.8k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 8.0k
- Cancer Research 3.8k
- Molecular Biology 12.4k
- Immunology 2.4k
- Aging 172
Countries citing papers authored by Weiya Xia
This map shows the geographic impact of Weiya Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiya Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiya Xia more than expected).
Fields of papers citing papers by Weiya Xia
This network shows the impact of papers produced by Weiya Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiya Xia. The network helps show where Weiya Xia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weiya Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 8 | |
| 2 | 2021 | 84 | |
| 3 | 2019 | 154 | |
| 4 | 2018 | 7 | |
| 5 | 2018 | 2 | |
| 6 | 2018 | 7 | |
| 7 | PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppressionbreakdown → | 2017 | 768 |
| 8 | 2016 | 203 | |
| 9 | S6K1 promotes invasiveness of breast cancer cells in a model of metastasis of triple-negative breast cancer. | 2014 | 38 |
| 10 | 2013 | 65 | |
| 11 | 2012 | 389 | |
| 12 | 2011 | 21 | |
| 13 | 2011 | 13 | |
| 14 | 2010 | 16 | |
| 15 | 2010 | 60 | |
| 16 | 2009 | 30 | |
| 17 | 2008 | 163 | |
| 18 | 2007 | 155 | |
| 19 | Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cellsbreakdown → | 2001 | 915 |
| 20 | Inhibition of intratracheal lung cancer development by systemic delivery of E1A. | 1996 | 20 |
About Weiya Xia
Weiya Xia is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 114 papers that have together received 18.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (19 papers), Virus-based gene therapy research (14 papers), RNA Interference and Gene Delivery (12 papers), Cancer Cells and Metastasis (10 papers), HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Epigenetics and DNA Methylation (10 papers) and Cell death mechanisms and regulation (9 papers). The work is most often cited by research in Oncology (8.0k citations), Cancer Research (3.8k citations) and Molecular Biology (12.4k citations). Weiya Xia has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Mien‐Chie Hung, Binhua P. Zhou, Bill Spohn, Yongkun Wei, Yong Liao, Gabriel N. Hortobágyi, Shiaw‐Yih Lin, Jiong Deng, Yong Wen and Mehmet Gündüz. Their work appears in journals such as Cancer Research, Molecular Carcinogenesis, Cancer Cell, Nature Cell Biology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.